Source: Virtual Congress 2021 – Acute COVID - 19



Rating:

Share or cite this content

Citations should be made in the following way:
P. Bridevaux (Sion, Switzerland), G. Gex (Sion, Switzerland), I. Frésard (Sion, Switzerland), P. Vremaroiu (Sion, Switzerland), N. Gobin (Sion, Switzerland), D. Lawi (Sion, Switzerland), R. Bouali (Sion, Switzerland). Comparison of COVID-19 mortality at the first and second wave adjusted for the 4C mortality score. 3973

Member's Comments

No comment yet.

Related content which might interest you: The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 The simplified acute physiology score 3 (SAPS 3) predicts mortality in an intermediate care unit (iCU) Source: Eur Respir J 2007; 30: Suppl. 51, 581s Year: 2007 Meta-analysis of FEV1 as a risk factor for all-cause mortality Source: Eur Respir J 2003; 22: Suppl. 45, 484s Year: 2003 Could a 2-year mortality prediction model have prevented deaths from respiratory failure: a single UK centre experience Source: Virtual Congress 2021 – Adult cystic fibrosis Year: 2021 Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk Source: Virtual Congress 2021 – COVID - 19 Year: 2021 Covid-19 and gender: lower rate, but same mortality of severe disease in women Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 COPD phenotypes and 5-years mortality risk prediction: PALOMB Cohort Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 The index distance-saturation product like predicting of mortality in patients with COPD Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment Year: 2008 Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality Source: Eur Respir J 2010; 36: 1002-1006 Year: 2010 Clinical outcomes and use of 4C mortality scoring in COVID-19 patients treated with Remdesivir in a large UK centre Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Severity assessment in CAP according to in-hospital mortality in two populations Source: Eur Respir J 2005; 26: Suppl. 49, 259s Year: 2005 Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness? Source: Eur Respir J 2005; 25: 587-588 Year: 2005 An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Copeptin predicts all-cause mortality in stable COPD: An analysis of the COSYCONET study Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Changes in physical activity and all-cause mortality in COPD Source: Eur Respir J 2014; 44: 1199-1209 Year: 2014 Treatment changes, readmission rates and mortality in a COPD hospital at home scheme Source: Eur Respir J 2005; 26: Suppl. 49, 286s Year: 2005 Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019 Year: 2019 A longitudinal study of the relationship between serial changes in BODE index, mortality and readmissions in patients with COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Analysis of NEWS2 trend to predict risk of death in COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010